<DOC>
	<DOCNO>NCT01842334</DOCNO>
	<brief_summary>1 . Compare relative efficacy ten week weekly 250 mg D-cycloserine ( DCS ) vs. placebo ( conjunction cognitive behavioral therapy ( CBT ) nicotine replacement therapy ( NRT ) reduce cigarette smoke treatment-seeking nicotine-dependent outpatient . 2 . Compare relative efficacy ten week weekly 250 mg DCS vs. placebo process extinction memory encode process .</brief_summary>
	<brief_title>D-cycloserine ( DCS ) Pretreatment + Cognitive Behavioral Therapy Nicotine Replacement Therapy Smoking Cessation ( DCS )</brief_title>
	<detailed_description>The investigator conduct Stage 1 pilot feasibility study McLean Hospital develop medication treat nicotine dependence . In randomized , double-blind , placebo-controlled trial , 40 nicotine-dependent participant age 18-65 receive cognitive behavioral therapy ( CBT ) nicotine replacement therapy ( NRT ) 10- week period , half receive D-cycloserine ( DCS ) pretreatment half receive placebo . Participants receive either 250 mg DCS placebo prior weekly CBT session addition NRT 10-week treatment period . The investigator also aim determine effect DCS performance neuropsychological test . A 10-week treatment period follow follow-up assessment include neuropsychological test 1 3 month post-treatment . Primary outcome include smoke measure carbon monoxide level self-report measurement .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>1 ) Age range 1865 year ; 2 ) DSMIV diagnosis nicotine dependence , base Structured Clinical Interview DSMIV ( SCID ) ( First et al . 1996 ) ; 3 ) express desire quit cigarette smoking within next 30 day ; 4 ) smoke great equal 10 cigarette per day le equal 20 cigarette per day ; 5 ) expire carbon monoxide ( CO ) determination great equal 10 ppm ambient value ; 6 ) woman childbearing age , negative pregnancy test screening agreement use adequate contraception prevent pregnancy multiple subsequent pregnancy test ; 7 ) consent u communicate prescribe clinician ; 8 ) furnish name 2 locator , would assist study staff locate study period ; 9 ) live close enough McLean Hospital attend study visit ; 10 ) plan remain Boston area next 4 month ; 11 ) willing able sign inform consent . 1 ) Current diagnosis drug alcohol dependence ( nicotine ) ; 2 ) significant cardiac disease ; 3 ) current serious psychiatric illness history psychosis , schizophrenia , bipolar type I disorder ( take psychiatric medication , aside wellbutrin , exclusionary criterion ) ; 4 ) current medical condition ( include significant laboratory abnormality , liver function test &gt; 5 time upper limit normal range ) could prevent regular study attendance ; 5 ) mental retardation organic mental disorder ; 6 ) exhibit acutely dangerous suicidal behavior ; 7 ) pregnant , nursing , , woman childbearing potential , use form birth control judge Principal Investigator effective ; 8 ) current NRT smoking cessation treatment ; 9 ) current CBT smoking cessation ; 10 ) current smokeless tobacco use ; 11 ) inability read write English ; 12 ) epilepsy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Nicotine Dependence</keyword>
	<keyword>Smoking Cessation</keyword>
	<keyword>D-cycloserine</keyword>
</DOC>